These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 9031085)

  • 1. Expression of erythroid-specific genes in megakaryoblastic disorders.
    Ito E; Kasai M; Toki T; Arai K; Yokoyama M
    Leuk Lymphoma; 1996 Nov; 23(5-6):545-50. PubMed ID: 9031085
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expression of erythroid-specific genes in acute megakaryoblastic leukaemia and transient myeloproliferative disorder in Down's syndrome.
    Ito E; Kasai M; Hayashi Y; Toki T; Arai K; Yokoyama S; Kato K; Tachibana N; Yamamoto M; Yokoyama M
    Br J Haematol; 1995 Jul; 90(3):607-14. PubMed ID: 7647001
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Frequent mutations in the GATA-1 gene in the transient myeloproliferative disorder of Down syndrome.
    Xu G; Nagano M; Kanezaki R; Toki T; Hayashi Y; Taketani T; Taki T; Mitui T; Koike K; Kato K; Imaizumi M; Sekine I; Ikeda Y; Hanada R; Sako M; Kudo K; Kojima S; Ohneda O; Yamamoto M; Ito E
    Blood; 2003 Oct; 102(8):2960-8. PubMed ID: 12816863
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mutations in GATA1 in both transient myeloproliferative disorder and acute megakaryoblastic leukemia of Down syndrome.
    Greene ME; Mundschau G; Wechsler J; McDevitt M; Gamis A; Karp J; Gurbuxani S; Arceci R; Crispino JD
    Blood Cells Mol Dis; 2003; 31(3):351-6. PubMed ID: 14636651
    [TBL] [Abstract][Full Text] [Related]  

  • 5. GATA1 mutations in Down syndrome: implications for biology and diagnosis of children with transient myeloproliferative disorder and acute megakaryoblastic leukemia.
    Crispino JD
    Pediatr Blood Cancer; 2005 Jan; 44(1):40-4. PubMed ID: 15390312
    [TBL] [Abstract][Full Text] [Related]  

  • 6. GATA1, cytidine deaminase, and the high cure rate of Down syndrome children with acute megakaryocytic leukemia.
    Ge Y; Stout ML; Tatman DA; Jensen TL; Buck S; Thomas RL; Ravindranath Y; Matherly LH; Taub JW
    J Natl Cancer Inst; 2005 Feb; 97(3):226-31. PubMed ID: 15687366
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prenatal origin of GATA1 mutations may be an initiating step in the development of megakaryocytic leukemia in Down syndrome.
    Taub JW; Mundschau G; Ge Y; Poulik JM; Qureshi F; Jensen T; James SJ; Matherly LH; Wechsler J; Crispino JD
    Blood; 2004 Sep; 104(5):1588-9. PubMed ID: 15317736
    [No Abstract]   [Full Text] [Related]  

  • 8. The proto-oncogene ERG in megakaryoblastic leukemias.
    Rainis L; Toki T; Pimanda JE; Rosenthal E; Machol K; Strehl S; Göttgens B; Ito E; Izraeli S
    Cancer Res; 2005 Sep; 65(17):7596-602. PubMed ID: 16140924
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mutagenesis of GATA1 is an initiating event in Down syndrome leukemogenesis.
    Mundschau G; Gurbuxani S; Gamis AS; Greene ME; Arceci RJ; Crispino JD
    Blood; 2003 Jun; 101(11):4298-300. PubMed ID: 12560215
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mutations in exon 2 of GATA1 are early events in megakaryocytic malignancies associated with trisomy 21.
    Rainis L; Bercovich D; Strehl S; Teigler-Schlegel A; Stark B; Trka J; Amariglio N; Biondi A; Muler I; Rechavi G; Kempski H; Haas OA; Izraeli S
    Blood; 2003 Aug; 102(3):981-6. PubMed ID: 12649131
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Origins of leukaemia in children with Down syndrome.
    Hitzler JK; Zipursky A
    Nat Rev Cancer; 2005 Jan; 5(1):11-20. PubMed ID: 15630411
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Coexpression of erythroid and megakaryocytic genes in acute erythroblastic (FAB M6) and megakaryoblastic (FAB M7) leukaemias.
    Linari S; Vannucchi AM; Ciolli S; Leoni F; Caporale R; Grossi A; Pagliai G; Santini V; Paoletti F; Ferrini PR
    Br J Haematol; 1998 Sep; 102(5):1335-7. PubMed ID: 9753066
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A leukemogenic twist for GATA1.
    Look AT
    Nat Genet; 2002 Sep; 32(1):83-4. PubMed ID: 12172549
    [No Abstract]   [Full Text] [Related]  

  • 14. Developmental stage-selective effect of somatically mutated leukemogenic transcription factor GATA1.
    Li Z; Godinho FJ; Klusmann JH; Garriga-Canut M; Yu C; Orkin SH
    Nat Genet; 2005 Jun; 37(6):613-9. PubMed ID: 15895080
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fetal origin of the GATA1 mutation in identical twins with transient myeloproliferative disorder and acute megakaryoblastic leukemia accompanying Down syndrome.
    Shimada A; Xu G; Toki T; Kimura H; Hayashi Y; Ito E
    Blood; 2004 Jan; 103(1):366. PubMed ID: 14684662
    [No Abstract]   [Full Text] [Related]  

  • 16. Transcription factor GATA-1 and Down syndrome leukemogenesis.
    Muntean AG; Ge Y; Taub JW; Crispino JD
    Leuk Lymphoma; 2006 Jun; 47(6):986-97. PubMed ID: 16840187
    [TBL] [Abstract][Full Text] [Related]  

  • 17. GATA1--a player in normal and leukemic megakaryopoiesis.
    Hitzler JK
    Pediatr Res; 2002 Dec; 52(6):831. PubMed ID: 12438656
    [No Abstract]   [Full Text] [Related]  

  • 18. Acquired mutations in GATA1 in the megakaryoblastic leukemia of Down syndrome.
    Wechsler J; Greene M; McDevitt MA; Anastasi J; Karp JE; Le Beau MM; Crispino JD
    Nat Genet; 2002 Sep; 32(1):148-52. PubMed ID: 12172547
    [TBL] [Abstract][Full Text] [Related]  

  • 19. GATA1 Is a Sensitive and Specific Nuclear Marker for Erythroid and Megakaryocytic Lineages.
    Lee WY; Weinberg OK; Pinkus GS
    Am J Clin Pathol; 2017 Apr; 147(4):420-426. PubMed ID: 28340113
    [TBL] [Abstract][Full Text] [Related]  

  • 20. RUNX1 and GATA-1 coexpression and cooperation in megakaryocytic differentiation.
    Elagib KE; Racke FK; Mogass M; Khetawat R; Delehanty LL; Goldfarb AN
    Blood; 2003 Jun; 101(11):4333-41. PubMed ID: 12576332
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.